Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) FCF Margin (2023 - 2025)

Historic FCF Margin for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to 5.02%.

  • Immunocore Holdings' FCF Margin fell 303100.0% to 5.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 59300.0%. This contributed to the annual value of 6.73% for FY2024, which is 77300.0% up from last year.
  • Latest data reveals that Immunocore Holdings reported FCF Margin of 5.02% as of Q3 2025, which was down 303100.0% from 26.08% recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' FCF Margin peaked at 30.69% during Q2 2024, and registered a low of 400.46% during Q4 2021.
  • For the 5-year period, Immunocore Holdings' FCF Margin averaged around 49.33%, with its median value being 3.64% (2025).
  • In the last 5 years, Immunocore Holdings' FCF Margin soared by 3749800bps in 2022 and then plummeted by -303100bps in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' FCF Margin stood at 400.46% in 2021, then skyrocketed by 94bps to 25.48% in 2022, then dropped by -4bps to 26.44% in 2023, then grew by 21bps to 20.86% in 2024, then skyrocketed by 76bps to 5.02% in 2025.
  • Its last three reported values are 5.02% in Q3 2025, 26.08% for Q2 2025, and 0.15% during Q1 2025.